U.S. Markets close in 3 hrs 52 mins

Acorda Therapeutics, Inc. (ACOR)


NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
22.9250+0.5250 (+2.3437%)
As of 12:04PM EDT. Market open.
People also watch
AMAGALNYACADBMRNSGEN
Show:
Income Statement
Balance Sheet
Cash Flow
Annual

Income Statement

All numbers in thousands
Revenue12/31/201612/31/201512/31/2014
Total Revenue519,601492,660401,480
Cost of Revenue108,10992,93180,615
Gross Profit411,492399,729320,865
Operating Expenses
Research Development203,437149,20973,470
Selling General and Administrative244,037216,530204,013
Non Recurring--6,991
Others---
Total Operating Expenses---
Operating Income or Loss-35,98233,99036,391
Income from Continuing Operations
Total Other Income/Expenses Net10,241851906
Earnings Before Interest and Taxes-25,74134,84137,297
Interest Expense16,52715,4729,288
Income Before Tax-42,26819,36928,009
Income Tax Expense-6,6658,31110,337
Minority Interest---
Net Income From Continuing Ops-34,61811,05817,672
Non-recurring Events
Discontinued Operations---
Extraordinary Items---
Effect Of Accounting Changes---
Other Items---
Net Income
Net Income-34,61811,05817,672
Preferred Stock And Other Adjustments---
Net Income Applicable To Common Shares-34,61811,05817,672